Find:

  • |
  • |

New prostate cancer test now available at the Spire Cambridge Lea Hospital

January 2009

The new PCA3 genetic test is now available as an outpatient procedure at the Spire Cambridge Lea Hospital.

Prostate Cancer gene 3 (PCA3) is a new gene-based test carried out on a urine sample. PCA3 is highly specific to prostate cancer and this gene is overexpressed in over 95% of prostate cancer cases.

The PCA3 test looks for the expression of genes found only in prostate cancer cells. Up to 100 times more PCA3 is present in prostate cancer cells than non-cancerous cells. By analysing cells from the prostate found in the urine the likelihood of having prostate cancer can be determined.

PSA Test

A high PSA test together with a positive PCA3 test is clinically significant and further tests such as biopsies may then be recommended.

Based only upon a raised PSA test, many men will undergo prostate biopsies unnecessarily - approximately only 1 out of 3 men having a biopsy will have prostate cancer.

For more information visit the websites our our consultants: Cambridge Urology Clinic and Cambridge Urology Partnership

Find a Hospital

Select from the menu above or enter a postcode below
Click on the map, select from the menu above or enter a postcode

Find by Postcode

Please enter details below to find your nearest hospital

     

Back to map

Find a Consultant

Use one or more of the options below to search for relevant consultants, then click on each name to read their detailed Spire profiles.

Name

Find a Treatment, Test or Scan

Select from the drop down list, enter a keyword, or use our interactive body map to locate treatments and procedures for each part of the body.

OR

Keyword

Enquire Now

  • To make an appointment please call 01223 266990
  • For the self pay treatment enquiries please call 01223 266929
  • For all other enquiries pleace call 01223 266900

© Spire Healthcare Limited (2010)